美達股份(000782.SZ):改聘中審亞太為公司2020年度財務及內控審計機構
格隆匯8月4日丨美達股份(000782.SZ)公佈,公司於2020年8月4日召開九屆董事會第十五次會議、九屆監事會第十二次會議,審議通過了《關於擬聘任會計師事務所的議案》,公司擬將聘任中審亞太會計師事務所(特殊普通合夥)為公司2020年度財務及內控審計機構,該事項尚需提交股東大會審議通過。
鑑於公司原聘審計機構立信會計師事務所(特殊普通合夥)已與公司合作長達十年,在2019年審計服務合同到期後,為確保審計工作的獨立性,提高上市公司審計工作質量,經與立信事務所溝通,決定2020年將不再聘任立信事務所為公司的財務及內控審計機構。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.